Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
90.78
+1.06 (1.18%)
At close: Jun 26, 2026, 4:00 PM EDT
91.35
+0.57 (0.63%)
After-hours: Jun 26, 2026, 7:11 PM EDT
Edwards Lifesciences Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Edwards Lifesciences stock have an average target of 97.33, with a low estimate of 85 and a high estimate of 110. The average target predicts an increase of 7.22% from the current stock price of 90.78.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Edwards Lifesciences stock from 29 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 16 | 17 | 17 | 17 |
| Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Hold | 12 | 12 | 10 | 8 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 33 | 33 | 31 | 30 | 29 | 29 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold Reiterates $87 | Hold | Reiterates | $87 | -4.16% | Jun 16, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 16, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $98 | Buy | Maintains | $98 | +7.95% | Jun 16, 2026 |
| Truist Financial | Truist Financial | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 16, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 16, 2026 |
Financial Forecast
Revenue This Year
6.75B
from 6.07B
Increased by 11.21%
Revenue Next Year
7.41B
from 6.75B
Increased by 9.82%
EPS This Year
3.01
from 2.56
Increased by 17.48%
EPS Next Year
3.37
from 3.01
Increased by 11.98%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.8B | 7.6B | |
| Avg | 6.7B | 7.4B | |
| Low | 6.6B | 7.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.3% | 12.2% | |
| Avg | 11.2% | 9.8% | |
| Low | 9.1% | 5.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.05 | 3.52 | |
| Avg | 3.01 | 3.37 | |
| Low | 2.97 | 3.30 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 19.1% | 17.0% | |
| Avg | 17.5% | 12.0% | |
| Low | 16.0% | 9.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.